[PDF] Top 20 Patents in the pharmaceutical industry
Has 10000 "Patents in the pharmaceutical industry" found on our website. Below are the top 20 most common "Patents in the pharmaceutical industry".
Patents in the pharmaceutical industry
... $ SDWHQW LV D PRQRSRO\ IRU D SHULRG RI WLPH HJ \HDUV OLPLWHG JHRJUDSKLFDOO\ ZKLFK JLYHV WKH SDWHQWHH WKH ULJKW WR H[FOXGH RWKHUV IURP PDNLQJXVLQJ VHOOLQJ RU RIIHULQJ WR VHOO WKH SDWHQWH[r] ... See full document
5
Window Analysis and Malmquist Index for Assessing Efficiency in a Pharmaceutical Industry
... assess the efficiencies of two packaging lines; Allfill (new) and DP6, in the Penicillin plant in a Jordanian Medical Company in ...2010. The CCR and BCC models are used to ... See full document
5
Is foreignness a source of competitive advantage in the Brazilian pharmaceutical industry?: an exploratory study
... (2010), in a study performed in Brazil, with companies listed at BMF&BOVESPA, to identify the relation between investment in working capital and the company value, concluded that ... See full document
43
On international cost-sharing of pharmaceutical RD
... proposed in the pharmaceutical industry as a principle to price discriminate among markets while allowing to recover the (fixed) R&D ...neglect the presence of insurance or ... See full document
18
Analysis of the importance of drug packaging quality for end users and pharmaceutical industry as a part of the quality management system
... on the importance of drug packaging quality to end users and pharmaceutical industry, as an indicator of the process of traceability and originality of ...among the end users of drugs ... See full document
9
Decomposing technological change at the twilight of the twentieth century: evidence and lessons from the world’s largest innovating firms
... examine the evolution of each industrial group of firms with respect to the changes in the technologies produced (patents obtained) by the entire group of 463 ...development ... See full document
25
M&A in the chinese pharmaceutical industry: Shanghai Pharma and SIPI/SZXP case study
... since the difficulty to calculate and ...all the synergies because of the narrow definition to synergies by executives at acquiring companies; the second problem is the missing of ... See full document
70
Strategic Development Trends in the World Pharmaceutical Industry
... world pharmaceutical market has undergone fast, unprecedented, tremendous and complex changes in the last several ...years. The phar- maceutical industry is today still one of ... See full document
17
An Interaction and Network Perspective of Horizontal Relationships in the Portuguese Pharmaceutical Industry
... Strategic alliances between competitors are of increasing importance and prevalence (Hitt, Dacin, Levitas, Arregle, & Borza, 2000; Leischnig, Geigenmueller, & Lohmann, 2014; N. Li, Boulding, & Staelin, 2010; ... See full document
304
Braz. J. Pharm. Sci. vol.51 número3
... organized in five areas: Pharmaceutical Assistance and Public Health, Industry and Technology, Clinical Analysis and Toxicology, Management and Regulatory Affairs, and Phar- maceutical ...speakers ... See full document
2
Rev. latinoam. psicopatol. fundam. vol.9 número2
... Over the past two decades a discussion has been going on about this partnership between prestigious names in the academic world and the pharmaceutical industry corrupting ... See full document
8
Braz. J. Pharm. Sci. vol.46 número1
... study in this paper was not intended to validate a portfolio management model for Brazilian phar- maceutical ...companies. The intention was to establish the important criteria for portfolio ... See full document
14
Mandatory disclosure of pharmaceutical industry-funded events for health professionals.
... for the educational content in only 9% of events (n = ...conducted in hospitals. The majority of events (n = 10,723, ...and in-service train- ing activities; only 4% (n = 591) were ... See full document
5
J. Braz. Chem. Soc. vol.22 número3
... Thus, the CDB provides for industrial development by those capable of achieving it in accordance with the proposed principles of biological and environmental ...on the exploration of ... See full document
1
The geography of knowledge spillovers in Europe
... working in a common industry. Patents linked by a citation are, thus, much more likely to share a geographic location than a pair of patents drawn at random from the entire pool of ... See full document
13
Astrazeneca and pharmaceutical industry: sector overview and company valuation
... In the USA, sales grew by 2.81% in 2014. In terms of medicines, Brilinta and Symbicort pushed sales up, offsetting the decrease felt in Nexium, Synagis and Seroquel ...was ... See full document
103
Key-works: pharmaceutical industry, Portuguese SME, exports, contract manufacturing,
... be the future for the Portuguese Pharmaceutical Companies? In the previous chapters it was shown how the failure of one company can become the fortune of another , through ... See full document
27
The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry
... and the firm providing it is a monopolist. The firm has the ability to set the price, p, of its ...that in many countries pharmaceutical prices are regulated, the initial ... See full document
20
Impact analysis of the implemented quality management system on business performances in pharmaceutical-chemical industry in Serbia
... Međunarodni standard menadžmenta kvaliteta ISO 9001 postao je opšte prihvatljivi okvir za unapređenje kvaliteta proizvoda i usluga, a sve je više istraživanja koja definišu veze i uticaje između primenjenog modela ... See full document
12
A country perspective in exploring the links between hospital pharmacies and pharmaceutical industry: a case study application
... for the pharmaceutical industry revealed the PSI scores (Pacific Sustainability Index (PSI) which uses two systemic questionnaires: one base questionnaire for reports across sectors and a ... See full document
8
temas relacionados